<![CDATA[EPCORE FL-1 Shows Efficacy and Safety of Epcoritamab Combination Therapy]]>

Data ReadoutpositiveepcoritamabR2Positive

AI Analysis

Summary

EPCORE FL-1 trial results demonstrate efficacy and safety of epcoritamab plus R2 combination therapy, with infection risk stabilizing after the first 4 treatment cycles.

Clinical Trial Data

Outcome Details

EPCORE FL-1 trial showed efficacy and safety of epcoritamab combination therapy; infection risk leveled off after first 4 cycles

Importance:6/10

Sentiment:

0.70

epcoritamabfollicular lymphomacombination therapyclinical trialsafetyefficacy

Related Companies

$TRAX

Read the original article

Published by Cancer Network on September 11, 2026 10:00 PM

Read Original